Commit Biologics has nominated COM002, its first development candidate from [...]

Nuformix has signed heads of terms to acquire Biovara, adding [...]

SeaBeLife has secured €2.9 million in French government funding to [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

Ananda Pharma has reported positive results from its Phase 1 [...]

Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]

Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive [...]

NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

Skyhawk Therapeutics has reported positive nine-month interim results from its [...]

AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]